Novavax’s new Covid vaccine is perfect for people scared of mRNA tech—but it won’t win over the unvaccinated
Novavax's new Covid vaccine is perfect for people scared of mRNA tech. Here's why experts say many of them still
Read MoreNovavax's new Covid vaccine is perfect for people scared of mRNA tech. Here's why experts say many of them still
Read MoreTravelers now need only one Covid-related document to enter Thailand — either a vaccination certificate or proof of a negative
Read MoreThe FDA has given vaccine-makers the green light to develop omicron-specific Covid vaccines. Here's what you should know about those
Read MoreWith Covid cases surging again, CNBC Make It spoke with several infectious disease expects about what Americans can expect this
Read MoreFormer Morgan Stanley Asia chairman Stephen Roach warns the U.S. is on a dangerous path that leads to higher prices
Read MoreCNBC Make It spoke with a series of long Covid experts about what to look out for, whether you're at
Read MoreMedical professionals are undecided on whether a fourth dose of the Covid-19 vaccine would benefit the wider population. Source link
Read MoreOmicron's global spread and large number of mutations suggest it could have a major impact on the Covid pandemic's course,
Read MoreMore than 20 people in the U.S. have tested positive for omicron. Here’s what we know about the cases so
Read More